- KR₩716bn
- KR₩743bn
- KR₩263bn
- 54
- 12
- 25
- 16
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 17.97 | ||
| PEG Ratio (f) | 0.19 | ||
| EPS Growth (f) | 2,444.47% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.27 | ||
| Price to Tang. Book | 3.34 | ||
| Price to Free Cashflow | 515.37 | ||
| Price to Sales | 2.42 | ||
| EV to EBITDA | 107.71 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.8% | ||
| Return on Equity | -7.09% | ||
| Operating Margin | -0.7% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 36,292.4 | 206,987.46 | 223,743.69 | 218,394.45 | 263,236.8 | 321,900 | 443,200 | 61.34% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -57.24 | -55.58 | n/a | n/a | +799.1 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bioneer Corp is a Korea-based company engaged in the biotechnology business. The Company mainly operates genetic research, molecular diagnostics, probiotics, and ribonucleic acid interference (RNAi) new drug development businesses. The Company mainly provides services such as gene analysis and synthesis, gene expression, and protein expression and purification. The Company’s products include body fat-reducing lactic acid bacteria in probiotics field, and basic materials, reagents, kits, gene extraction, amplification, quantitative analysis equipment, molecular diagnosis equipment for genetic research and molecular diagnosis used in molecular diagnosis field. The Company also provides laboratory equipment, single products, and laboratory consumables used in biotech research.
Directors
- Han Oh Park CEO (51)
- Jin Pyeong Jung OTH (49)
- Jae Ha Kim OTH (50)
- Jae Don Lee OTH (53)
- Han Yi Park OTH (48)
- Gyu Yil Nah OTH (62)
- Yong Moon DRC (49)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- August 28th, 1992
- Public Since
- December 29th, 2005
- No. of Shareholders
- 48,015
- No. of Employees
- 281
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Korea Exchange - KOSDAQ- Shares in Issue
- 25,810,291
- Address
- 71 Techno 2-ro, Yuseong-gu, DAEJEON, 34013
- Web
- https://www.bioneer.co.kr/
- Phone
- +82 429368500
- Auditors
- Tae Sung Accounting
Upcoming Events for 064550
Similar to 064550
ABion
Korea Exchange - KOSDAQ
ABL Bio
Korea Exchange - KOSDAQ
Amicogen
Korea Exchange - KOSDAQ
AprilBio Co
Korea Exchange - KOSDAQ
AptaBio Therapeutics
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:36 UTC, shares in Bioneer are trading at KR₩27,750. This share price information is delayed by 15 minutes.
Shares in Bioneer last closed at KR₩27,750 and the price had moved by -21.08% over the past 365 days. In terms of relative price strength the Bioneer share price has underperformed the FTSE Developed Asia Pacific Index by -31.24% over the past year.
There is no consensus recommendation for this security.
Find out moreBioneer does not currently pay a dividend.
Bioneer does not currently pay a dividend.
Bioneer does not currently pay a dividend.
To buy shares in Bioneer you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩27,750, shares in Bioneer had a market capitalisation of KR₩716bn.
Here are the trading details for Bioneer:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 064550
Based on an overall assessment of its quality, value and momentum Bioneer is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioneer. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -6.51%.
As of the last closing price of KR₩27,750, shares in Bioneer were trading -7.54% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bioneer PE ratio based on its reported earnings over the past 12 months is 17.97. The shares last closed at KR₩27,750.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Bioneer's management team is headed by:
- Han Oh Park - CEO
- Jin Pyeong Jung - OTH
- Jae Ha Kim - OTH
- Jae Don Lee - OTH
- Han Yi Park - OTH
- Gyu Yil Nah - OTH
- Yong Moon - DRC